Join

Compare · CBOE vs IBBJ

CBOE vs IBBJ

Side-by-side comparison of Cboe Global Markets, Inc. (CBOE) and Defiance Nasdaq Junior Biotechnology ETF (IBBJ): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CBOE and IBBJ operate in n/a (n/a), so they compete in similar markets.
  • CBOE carries a market cap of $13.01B.
  • CBOE has hit the wire 3 times in the past 4 weeks while IBBJ has been quiet.
  • CBOE has more recent analyst coverage (25 ratings vs 0 for IBBJ).
MetricCBOEIBBJ
Company
Cboe Global Markets, Inc.
Defiance Nasdaq Junior Biotechnology ETF
Price
$303.52+0.98%
$29.45-10.89%
Market cap
$13.01B
-
1M return
+9.45%
-
1Y return
+43.01%
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
2010
n/a
News (4w)
3
0
Recent ratings
25
0
CBOE

Cboe Global Markets, Inc.

Cboe Global Markets, Inc., through its subsidiaries, operates as an options exchange worldwide. It operates through five segments: Options, North American Equities, Futures, European Equities, and Global FX. The Options segment trades in listed market indices. The North American Equities segment trades in listed U.S. and Canadian equities; and offers exchange-traded products (ETP) transaction and ETP listing services. The Futures segment trades in futures. The European Equities segment offers pan-European listed equities transaction services, ETPs, exchange-traded commodities, and international depository receipts, as well as ETP listings and clearing services. The Global FX segment provides institutional foreign exchange (FX) trading and non-deliverable forward FX transactions services. The company has strategic relationships with S&P Dow Jones Indices, LLC; FTSE International Limited; Frank Russell Company; MSCI Inc.; and DJI Opco, LLC. The company was formerly known as CBOE Holdings, Inc. and changed its name to Cboe Global Markets, Inc. in October 2017. Cboe Global Markets, Inc. was founded in 1973 and is headquartered in Chicago, Illinois.

IBBJ

Defiance Nasdaq Junior Biotechnology ETF

The investment seeks to track the total return performance, before fees and expenses, of the NASDAQ Junior Biotechnology Index. The index is a rules-based index that consists of a portfolio of the stock of U.S.-listed small capitalization ("junior") companies screened from the universe of the NASDAQ Biotechnology Index. The fund will generally use a "replication" strategy to achieve its investment objective, meaning it will generally invest in all of the component securities of the index in the same approximate proportions as in the index. The fund is non-diversified.